Announcements

24. June 2020

New research group “Computational Virology” at TWINCORE

Group leader Chris Lauber funded by RESIST


07. May 2020

Fraunhofer Research consortium iCAIR® makes use of synergies to develop new medications against SARS-CoV-2

With its rapid spread around the world, the new coronavirus SARS-CoV-2 has triggered a public health emergency of international concern. To date, there is neither a vaccine nor drugs for treating COVID-19 patients available....


24. April 2020

Searching for drugs against SARS-CoV-2

RESIST-Scientist Professor Pietschmann, head of the TWINCORE Insitute for Experimental Virology, leads the German part of an international consortium of scientists. This research network is searching for substances that act...


[ Show all ]

What does translational infection research mean in practice? How do we bridge basic research and clinical challenges? What kind of impulses and questions do our scientists get from the clinical environment? Our new rubric "translational case examples" shows how we combine basic research and clinical questions and what drives our science.

Internationality...

...is an important characteristic of our institute. International networking and stimuli  encourage the quality of our research and it is an additional value for our scientific work. There are more than 40 scientists from over 20 nations working at TWINCORE. Learn more about our cooperations and international exchange programmes.

30. September 2020

Lecture Series - Regulatory Science and Translational Research

Dr. Christian Schneider, Director of the National Institute for Biological Standards and Control (NIBSC) in the UK, Part 1: Why is knowledge in regulatory science important for translational medicine and basic...


[ Show all ]